Authors: SEMERARO C MARCHINI F FERLENGA P MASOTTO C MORAZZONI G PRADELLA L POCCHIARI F

Citation: C. Semeraro et al., THE ROLE OF DOPAMINERGIC AGONISTS IN CONGESTIVE-HEART-FAILURE, Clinical and experimental hypertension, 19(1-2), 1997, pp. 201-215

Authors: NAPOLETANO M DELLA BD FRAIRE C GRANCINI G MASOTTO C RICCIARDI S ZAMBON C

Citation: M. Napoletano et al., STEREOSELECTIVE SYNTHESIS AND EVALUATION OF ALL STEREOISOMERS OF Z4349, A NOVEL AND SELECTIVE MU-OPIOID ANALGESIC, Bioorganic & medicinal chemistry letters, 5(6), 1995, pp. 589-592

Authors: BRUNELLO N MASOTTO C STEARDO L MARKSTEIN R RACAGNI G

Citation: N. Brunello et al., NEW INSIGHTS INTO THE BIOLOGY OF SCHIZOPHRENIA THROUGH THE MECHANISM OF ACTION OF CLOZAPINE, Neuropsychopharmacology, 13(3), 1995, pp. 177-213

Authors: MASOTTO C BISIANI C CAMISASCA C FUSI R RICCIARDI S FONZI N PERBELLINI L SCATTURIN M MARIANI CB CANESI M PEZZOLI G

Citation: C. Masotto et al., EFFECTS OF ACUTE N-HEXANE AND 2,5-HEXANEDIONE TREATMENT ON THE STRIATAL DOPAMINERGIC SYSTEM IN MICE, Journal of neural transmission. Supplementum, (45), 1995, pp. 281-285

Authors: RICCIARDI S BISIANI C CAMISASCA C FUSI R ORNAGHI F PASTORIS R SCATTURIN M MASOTTO C

Citation: S. Ricciardi et al., BEHAVIORAL AND BIOCHEMICAL EFFECTS OF A NEW POTENTIAL NOOTROPIC AGENT- Z4105, Journal of drug development, 6(4), 1994, pp. 159-170